JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bishop, L. P. D.
Right arrow Articles by Park, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishop, L. P. D.
Right arrow Articles by Park, B. K.

Vol. 289, Issue 1, 511-520, April 1999

Metabolism of the Antimalarial Endoperoxide Ro 42-1611 (Arteflene) in the Rat: Evidence for Endoperoxide Bioactivation1

Laurence P. D. Bishop, James L. Maggs, Paul M. O'Neill and B. Kevin Park

Departments of Pharmacology and Therapeutics (L.P.D.B., J.L.M., B.K.P.) and Chemistry (P.M.O.), University of Liverpool, Liverpool, United Kingdom

Ro 42-1611 (arteflene) is a synthetic endoperoxide antimalarial. The antimalarial activity of endoperoxides is attributed to iron(II)-mediated generation of carbon-centered radicals. An alpha ,beta -unsaturated ketone (enone; 4-[2',4' bis(trifluoromethyl)phenyl]-3-buten-2-one), obtained from arteflene by reaction with iron(II), was identified previously as the stable product of a reaction that, by inference, also yields a cyclohexyl radical. The activation of arteflene in vivo has been characterized with particular reference to enone formation. [14C]Arteflene (35 µmol/kg) was given i.v. to anesthetized and cannulated male rats: 42.2 ± 7.0% (mean ± S.D., n = 7) of the radiolabel was recovered in bile over 5 h. In the majority of rats, the principal biliary metabolites were 8-hydroxyarteflene glucuronide (14.2 ± 3.9% dose, 0-3 h) and the cis and trans isomers of the enone (13.5 ± 4.6% dose, 0-3 h). In conscious rats, 15.3 ± 1.6% (mean ± S.D., n = 8) of the radiolabel was recovered in urine over 24 h. The principal urinary metabolite appeared to be a glycine conjugate of a derivative of the enone. Biliary excretion of the glucuronide, but not of the enones, was inhibited by ketoconazole. 8-Hydroxyarteflene was formed extensively by rat and human liver microsomes but no enone was found. Bioactivation is a major pathway of arteflene's metabolism in the rat. Although the mechanism of in vivo bioactivation is unclear, the reaction is not catalyzed by microsomal cytochrome P-450 enzymes.


0022-3565/99/2891-0511$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. L. Maggs, L. P. D. Bishop, G. Edwards, P. M. O'Neill, S. A. Ward, P. A. Winstanley, and B. K. Park
Biliary Metabolites of beta -Artemether in Rats: Biotransformations of an Antimalarial Endoperoxide
Drug Metab. Dispos., February 1, 2000; 28(2): 209 - 217.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.